Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia
NCT03548155
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Therapeutics
Interventions
DRUG:
Berberine
DRUG:
atypical antipsychotic
DRUG:
placebo
Sponsor
Tianjin Anding Hospital